Questions institutional buyers ask before commissioning an execution-risk read.

Purple Wins establishes execution risk as a measurable financial risk class. Boards already govern financial, credit, market, cyber and safety risk against reference points. Execution risk — whether the organization can convert a decision into the intended result — is governed on judgement alone, because no comparable evidence exists.

Purple Wins builds that evidence in two ways: through NAVETRA, the measurement instrument, and by convening Canada's Founding Manufacturing & Distribution Execution Benchmark, which establishes the sector reference against which an individual reading can be interpreted.

Where an organization or a partner consultancy wants to carry the measurement itself, Purple Wins provides NAVETRA operations support and trains partner consultants on the model.

NAVETRA™ is Purple Wins' proprietary execution-intelligence measurement instrument. It collects standardized evidence from multiple leaders inside an organization, reads the execution conditions that determine whether a commitment lands, and returns an evidence-based range together with the coverage and limitations of the evidence it was given.

NAVETRA is used inside Purple Wins engagements and inside the benchmark. It also supports recurring measurement through NAVETRA Enterprise where an organization wants execution risk carried in its governance cycle.

Purple Wins is the company and the convener. NAVETRA is the instrument used to measure. Canada's Founding Manufacturing & Distribution Execution Benchmark is convened by Purple Wins; NAVETRA is the instrument used within it. NAVETRA does not invite, recruit or establish the cohort — Purple Wins does.

Purple Wins is based in the Niagara Region, Ontario, Canada. The 2026 founding benchmark is a Canadian initiative. Live-decision engagements are undertaken with organizations in Canada and internationally where the sector reference information supports a defensible read.

Execution risk is the risk that an organization does not convert a decision into the result the decision assumed. It sits inside every business case as an unstated premise: that the alignment, leadership capacity, cross-functional coordination, knowledge continuity and operating conditions required to deliver already exist.

It is usually confirmed after a loss, in a post-mortem. Measuring it before the commitment is the point of the instrument.

Operating Profit at Risk is an evidence-based, confidence-rated range of operating profit exposure associated with the execution conditions surrounding a defined decision, with assumptions and limitations clearly stated. It gives leadership an economic view of the exposure, where it is concentrated and how strong the underlying evidence is.

No. It is not an audited financial measure, not actuarially certain, not a prediction of a specific loss, not a guaranteed saving and not a guarantee of performance. It is decision-support information expressed as a range rather than a point estimate.

It supports executive judgement; it does not replace it, or the organization's own financial, legal and risk advisers.

No. An OPaR range is part of the Founding Organization engagement and is produced only where the evidence supports one. Where it does not, that is stated rather than estimated. Evidence coverage, confidence, assumptions and limitations are reported alongside any range.

Organizational execution conditions — the conditions that determine whether a commitment converts into a result. Evidence is collected across ten domains:

• Organization Alignment
• Executive Alignment
• Leadership Bandwidth
• Team Effectiveness
• Knowledge Retention, Sharing & Transfer
• Technology & AI Readiness
• Cross-Functional Collaboration
• Talent & Hiring Alignment
• Sales Readiness / Revenue Conversion
• Resilience & Risk Management

An engagement instrument measures how people feel about working somewhere, usually across the whole population, and reports sentiment. NAVETRA measures whether specific organizational conditions required to deliver a specific commitment are present, using structured evidence from a small number of leaders who hold different vantage points on the same execution question, and expresses the result in operating-profit terms.

The audience differs accordingly. Engagement results go to the people function. An execution read goes to the executive team and the board, before capital is committed.

No. NAVETRA measures organizational conditions, not people. It produces no individual ratings, rankings, scores or performance judgements, and it is not designed or licensed for use in performance management, compensation or employment decisions. Individual responses are not attributed in reporting.

It is not implementation consulting or an embedded delivery engagement. NAVETRA is a measurement instrument applied to one defined decision. Where repeated measurement is useful, execution governance may be separately scoped.

Purple Wins provides NAVETRA operations support where an organization asks for it, and trains partner consultants to work with the model. Neither is a condition of a reading, and neither is scoped inside a benchmark engagement.

It is not an audit, not a project-management review, not an employee sentiment instrument, not a culture assessment, not implementation delivery, not a prediction of a specific loss and not a guarantee of results. It does not judge whether a strategy is correct; it examines whether the organization expected to deliver it has the conditions to do so.

The chief executive facing the next hard decision under uncertainty, together with the board chair, CFO and COO who carry that decision with them. Typically manufacturing, distribution and industrial organizations where a commitment is large enough that a delivery failure would be visible in operating profit.

Before the commitment, not after the disappointment. The common triggers are a capacity or plant investment, an ERP or technology implementation, an AI deployment, a supply-chain or network redesign, an acquisition or post-close integration, a growth programme, a restructuring, a dealer or channel transformation, or a leadership succession.

It is also used where a board has asked a question that existing reporting cannot answer: whether the organization can actually deliver what has been approved.

Organizations wanting a sentiment read, a culture programme or implementation delivery. Organizations that cannot involve multiple leaders — a single respondent cannot produce a defensible reading of organizational conditions, so single-respondent engagements are not accepted.

A read anchored to one live decision. The boundary of the decision is defined before evidence collection begins, the contributing leaders are identified, evidence is collected in standardized form, and the organization receives an interpretation of the execution conditions surrounding that specific commitment.

Anchoring to one decision is deliberate. A general organizational reading tends to produce general observations; a bounded decision produces evidence that can be used.

Scope follows the decision: its boundary, the leaders whose evidence is required, and whether organizational documents are needed. Fees are agreed in writing before work begins, with a defined deliverable and a defined end date.

Through the 2026 founding cohort, the Founding Organization engagement is offered at CAD $6,400 per organization for one defined, material decision. Engagements outside the founding cohort are scoped individually.

One founding Canadian initiative. Two distinct sector cohorts — Manufacturing and Distribution — on a common measurement foundation, with sector-specific comparison and interpretation. Two participation routes.

Details and application: the benchmark page.

Purple Wins convenes it. NAVETRA is the measurement instrument used within it. Purple Wins confirms eligibility, sector cohort and participation; the instrument does not.

Canadian manufacturing and distribution organizations with an executive sponsor at CEO, president, COO or CFO level, able to complete evidence contribution inside the defined window. Research Participants involve three to five leaders; Founding Organizations typically involve five to six decision-relevant leaders, with additional participants only where the defined decision requires them. Fit is confirmed by review; applying does not guarantee acceptance.

Research Participants involve three to five leaders. Founding Organizations typically involve five to six decision-relevant leaders, with additional participants only where the defined decision requires them. Approximately 30–45 minutes per contributing leader, once, inside the window. There is no recurring time commitment.

No. There is no obligation to purchase anything at any stage. Research Participation is complete in itself, and declining to continue does not affect the Evidence Coverage Summary, the aggregate sector findings or the invitation to the findings briefing.

Eligibility and fit confirmation, participation in the standardized evidence protocol, confirmation that completed evidence met the applicable inclusion threshold, aggregate sector findings when approved reporting thresholds are satisfied, an invitation to the findings briefing, and optional recognition only with explicit written permission.

The only individual artifact is an Evidence Coverage Summary, stating whether required evidence categories were complete, incomplete or unavailable. It contains no score, no exposure result, no diagnosis, no interpretation and no recommendation.

Research Participation does not return an organization-specific baseline, an OPaR range, a detailed domain profile, organization-specific interpretation, recommendations, a 90-day action map, a bespoke peer comparison or a board-ready organizational report.

Twelve deliverables, for one defined, material decision:

• 01 · Decision and scope confirmation
• 02 · Standardized multi-respondent evidence collection
• 03 · Decision-specific execution-risk baseline
• 04 · Ten-domain execution profile
• 05 · Evidence-based, confidence-rated OPaR range with assumptions and limitations clearly stated
• 06 · Exposure concentration and priority sequence
• 07 · Executive evidence-validation session
• 08 · Executive interpretation
• 09 · Decision and operating-profit implications
• 10 · Prioritized 90-day action map
• 11 · Board-ready report
• 12 · Facilitated executive presentation

CAD $6,400 is the founding-cohort price, per organization. There are no additional founding-cohort prices, discounts or packages.

Research Participation contributes standardized evidence to the sector evidence base and returns aggregate findings. The Founding Organization engagement produces organization-specific evidence and interpretation leadership can decide against, anchored to one defined, material decision.

The distinction is not report length. It is whether the evidence has been read for your organization at all.

Recurring measurement and governance of execution risk, scoped separately from any benchmark participation. It comprises re-reads at an agreed cadence, reconciliation against the organization's own evidence record over time, and — only where contractually and technically applicable — multi-unit or leadership views.

No. A single read is complete in itself. Enterprise is relevant where an organization wants execution risk to appear in the governance cycle repeatedly rather than once, and where the value is in movement over time rather than a single reading.

Scoped and priced individually against cadence, organizational scope and the views required. Terms are agreed in writing before deployment.

Structured evidence contributed by the participating leaders, plus basic organizational classification information such as sector, size band and province.

No system access or full financial-statement upload is required. For paid engagements, limited decision-level operating and financial context is agreed in advance where required to support OPaR interpretation.

No system integration is required for benchmark participation or for an initial decision-specific read. Where any connector or data feed is used within an Enterprise deployment, it is client-controlled and configured only under the applicable agreement.

It is reported as insufficient. Evidence coverage and limitations are shown alongside every reading, and where the evidence does not support a range, no range is produced. Purple Wins will identify what additional evidence would be required, and the organization decides whether to supply it.

An instrument that produces a confident figure regardless of input is not measuring anything. Refusing to produce one is a feature of the method, not a failure of it.

No. Organization-specific results, ranges and exposure concentrations are returned only to that organization and are not published. Organization names and logos are not published without written permission, and participation does not itself authorize public identification.

Individual responses are confidential, and organizations are not named publicly without written permission. The participation terms will set out collection, access, retention and permitted publication before the organization commits.

Aggregate findings will only be published where approved reporting and disclosure thresholds are satisfied.

No. Individual responses and comments are not attributed to named individuals in reporting to the organization or in cohort reporting.

Contact details submitted through the website, information provided in an application or enquiry, evidence contributed by participating leaders, and standard technical information such as IP address, browser type and cookie identifiers. Personal information is not sold or rented.

Collection, use, retention and any service providers involved are described in the Privacy Policy and, for an engagement, in the applicable agreement and any data-processing terms. Retention periods, hosting arrangements and security controls are addressed there rather than on this page.

Write to admin@purplewins.io or use the contact page, stating what is requested — access, correction, withdrawal of consent or deletion. Requests are handled in accordance with applicable privacy law.

Client-identifiable evidence is not used to train shared models, and would not be without explicit written agreement. Any use of de-identified information for reference purposes is governed by the applicable agreement.

NAVETRA uses a documented, evidence-based approach that produces a range, makes input coverage and assumptions visible, and uses sector-aware reference information. Detailed proprietary methodology may be reviewed under appropriate confidentiality where required — for example in enterprise procurement, board assurance or investor diligence.

Weighting logic, formulas, calibration, thresholds, model architecture and taxonomy mechanics are not published.

Sector-aware reference information may inform interpretation where permitted and appropriate, alongside sector information drawn from public regulatory disclosures and published research. It does not replace the organization's own evidence.

Because a point estimate would misrepresent what the evidence can support. A range, reported with its coverage and limitations, is defensible in front of a CFO and a board. A single confident figure is not.

No. NAVETRA measures conditions before a commitment; it does not control what happens after one. It cannot guarantee performance, delivery, a financial result, or that a decision will succeed. It informs a decision — it does not make one.

Findings should not be used as an audited financial measure, as a substitute for financial, legal, investment or actuarial advice, or as an input to individual performance, compensation or employment decisions. They should be reviewed alongside the organization's own financial, legal, risk and operational advisers.

A reading reflects the conditions present at the time evidence was collected, from the leaders who contributed it, within the boundary of the decision defined. Coverage gaps, respondent composition and the scope boundary are reported with the findings so that the reader can judge how far the reading extends.

• Apply to the 2026 founding cohort on the benchmark page, as a Research Participant or as a CAD $6,400 Founding Organization.
• Ask a confidential question, or request a short fit conversation, via the contact page.
• Discuss recurring execution governance, scoped separately, via the NAVETRA page.

Purple Wins reviews the application, confirms eligibility and sector cohort, and arranges a short fit conversation where useful. Confirmed participants then identify their contributing leaders before the evidence window opens. Applying does not add anyone to a marketing list.

No. Places are confirmed by fit review, not by order of application. Where the founding cohort is not the right setting for an organization, Purple Wins will say so directly.

Yes. Industry associations, innovation organizations and advisory firms work with Purple Wins to bring sector-level execution measurement to their members, typically as a defined sector cohort with aggregate findings returned to the sector. Terms are agreed in writing in each case.

Yes. Purple Wins trains partner consultants to interpret and apply the model inside their own client engagements, under written agreement. The client relationship and any delivery work remain the partner's; the measurement standard, its interpretation and the reference information remain Purple Wins'.

Terms, scope and the conditions under which a partner may represent a NAVETRA reading are set out in the partner agreement.

Possibly. Partner-sponsored sector studies may carry different deliverables and terms under the partner invitation. Follow the participation details provided in that invitation, and contact Purple Wins if anything is unclear.

Confirmed sessions and speaking dates are listed on the Meet Us page.